Aromatherapy and Pain
WithdrawnNot applicableNCT05910892
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.
Study details
- Official title
- The Effect of Aromatherapy on the Incidence and Severity of Post Procedure Pain and Discomfort in Patients
- Conditions
- Interventions
- Drug: Aromatherapy packet
- Drug: Placebo packet
- Sponsor
- University of Washington
- Start date
- 2025-01
- Primary completion
- 2025-07
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Have received at least one (1) prior IMS or trigger point injection treatment with researcher * 18 years of age or older * English language speaker * has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit * any analgesic medication taken must be consistent for both sessions Exclusion Criteria: * Non-English language speaker * Age \<18 * Allergy to essential oils * Asthmatic * Patient unable to self-administer aromatherapy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05910892